Triptorelin Market Trends

  • Report ID: 5019
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Triptorelin Market Trends

Growth Drivers

  • Growing Prevalence of HIV

According to the World Health Organization, about 38.4 million people worldwide were living with HIV in 2021. Hence, there has been going numerous trials to check the efficiency of triptorelin in HIV patient. However, even though this treatment is not widely used in HIV patients, owing to the ongoing research & development and huge investment from the pharmaceutical organization for the same, triptorelin treatment is estimated to be used to treat such patients during the forecast timeframe.

  • Rise in Prostate Cancer Among Men

The second most frequently diagnosed cancer and the fifth highest cause of cancer death in males globally is considered to be prostate cancer, with a poised 1,414,000 new cancer cases and 375,304 deaths in 2020. The hormone testosterone is required for prostate cancer to develop. The testicles in men produce almost all of the testosterone. Triptorelin inhibits testosterone production in the testicles, lowering testosterone levels and slowing or halting the proliferation of cancer cells.

  • Surge in the Number of Women Suffering from Endometriosis

According to the World Health Organization, globally about 10% or 190 million women or girls of reproductive age are affected by endometriosis. It causes life-impacting pain in women during sexual intercourse, periods, bowel moment, and more. Hence, its treatment is necessary. Therefore, the use of triptorelin is growing since it has been proven effective with an acceptable safety profile. Also, since it has positive results on the reproductive part of the women, the problem in becoming could be diagnosed.

Challenges

  • High Price of Triptorelin Drugs - Despite having a huge client base, the triptorelin market has a significant obstacle which includes expensive triptorelin drug manufacturing costs, which are passed down to consumers as high medical costs. The expense of manufacturing a drug is further boosted by the fact that the raw materials are unique to the drug, making it essential that they be of high quality. Additionally, the product availability is hindered to those who could afford it owing to the intricacy of the triptorelin manufacturing process, which involves a variety of biological or chemical procedures.
  • Side Effects of Triptorelin
  • Lack of Awareness Among People

Triptorelin Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5%

Base Year Market Size (2023)

USD 10.53 Billion

Forecast Year Market Size (2036)

USD 20.61 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5019
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of triptorelin is estimated at USD 11.06 Billion.

The triptorelin market size was valued at USD 10.53 Billion in 2023 and is likely to reach USD 20.61 Billion by 2036, registering around 5.3% CAGR during the forecast period i.e., between 2024-2036. The major factors driving the growth of the market are the growing prevalence of HIV, the rise in prostate cancer among people, and the surge in the number of women suffering from endometriosis.

North America industry is set to have the highest gain by 2036, backed by growing demand for hormone therapy among men.

Ipsen Pharma, Bachem, Chengdu Tiantaishan pharmaceutical, Ferring Pharmaceuticals, Tecnofarma SA, Dr. Reddy's Laboratories Ltd, Arbor Pharmaceutical, Inc., Teva Pharmaceutical Industries Ltd., Debiopharm International SA, Verity Pharmaceuticals Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample